Mylan Draws 483 for Cleaning and Maintenance, Quality Control Issues

By Sam | June 29, 2018

A heavily staffed FDA inspection of pharmaceutical giant Mylan’s manufacturing facility in Morgantown, West Virginia netted the company a lengthy Form 483 listing numerous deficiencies in the firm’s quality control unit.
Source: Drug Industry Daily

Posted in Drug Industry Daily